Provided by Tiger Trade Technology Pte. Ltd.

Incyte

123.22
-1.1500-0.92%
Post-market: 123.220.00000.00%16:24 EDT
Volume:1.48M
Turnover:182.66M
Market Cap:24.98B
PE:15.70
High:124.00
Open:122.66
Low:121.61
Close:124.37
52wk High:132.60
52wk Low:81.09
Shares:202.70M
Float Shares:169.82M
Volume Ratio:1.58
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.94
PE(LYR):19.22

Loading ...

Opzelura® (Ruxolitinib) Cream Becomes First Steroid-Free Topical Jak Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis

THOMSON REUTERS
·
Jul 29

Incyte Corporation : Barclays Raises Target Price to $139 from $134

THOMSON REUTERS
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), Centene (CNC) and Incyte (INCY)

TIPRANKS
·
Jul 29

Incyte : Guggenheim Raises Target Price to $150 from $136

THOMSON REUTERS
·
Jul 29

Incyte Corp. Stock Advances 9.3%, Outperforms Peers

Dow Jones
·
Jul 29

Incyte up over 10%, on Track for Highest Close Since September 2017

Dow Jones
·
Jul 29

Incyte Reports Strong Commercial Growth with 38% Revenue Surge and Upgraded Full-Year Forecast

Deep News
·
Jul 29

Incyte Says It's No Longer A One-Drug Story

Benzinga Earnings
·
Jul 29

Top Midday Gainers

MT Newswires Live
·
Jul 29

U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab

Reuters
·
Jul 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 29

Incyte price target raised to $145 from $123 at Stifel

TIPRANKS
·
Jul 29

Wells Fargo Adjusts Price Target on Incyte to $116 From $101

MT Newswires Live
·
Jul 29

Prelude Therapeutics rallies after Incyte prioritizes JAK2V617F pipeline

TIPRANKS
·
Jul 28

Movement Alert|Incyte Intraday Rise 5.24%, Q2 Earnings Significantly Beat Expectations with Full-Year Revenue Guidance Raised

Market Focus
·
Jul 28

Stock Track | Incyte Soars 5% in Intraday Trading on Q2 Earnings Beat and Raised Annual Revenue Guidance

Stock Track
·
Jul 28

Incyte Lifts Annual Revenue Forecast After Settlement with CMS

Reuters
·
Jul 28

Incyte Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Kiniksa Pharmaceuticals Q2 Product Revenue Rises on Arcalyst Sales

Reuters
·
Jul 28

Incyte Q2 Non-GAAP Earnings, Revenue Rise; Raises 2026 Sales Guidance

MT Newswires Live
·
Jul 28